, Inc. (CIIX) Combating Alzheimer’s Disease through Development of CBD Health Products

China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy. Unfortunately, China’s longer-lived population has resulted in a significant increase in the number of people having to care for seniors with various mental dysfunctions, most notably dementia and, in particular, Alzheimer’s disease.

Alzheimer’s is a neurodegenerative type of dementia that is most prominent in elderly people. The disease is a disorder that involves the death of brain cells leading to various cases of memory loss and cognitive decline. The disease starts mildly but eventually progresses to the point that patients affected often cannot recognize familiar surroundings and eventually lose almost all of their short term memory capabilities.

Recent statistics show that over 1,300 people aged 60 or over get lost or go missing every day in China ( Dementia of various forms was said to be the main cause of these disappearances. More than 70% of the elderly people who go missing have memory problems, with 25% of these having Alzheimer’s disease.

Alzheimer’s cases now makes up more than 60% of all dementia patients in China, and, because people are living longer, the number of people affected by the disease is growing rapidly., Inc. (OTCQB: CIIX), a company focused on sharing real-time market analysis to Chinese-speaking investors and which also has the aim of becoming the premier producer of cannabidiol (CBD) oil to mainland China, is hoping to help manage this growing problem.

Recent studies show that Alzheimer’s is a disease that affects the whole nervous system (, not just the brain. This means that strengthening the endocannabinoid system is extremely important to managing symptoms of Alzheimer’s, something of which CIIX is very aware. From various research, the company has found that CBD oil can be effective in restoring memory, and it plans to further study the efficacy of CBD oil for the treatment of Alzheimer’s disease.

In addition to the launch of, the world’s first online CBD health products store in Chinese, and its cannabis mobile application, will be investing in CBD drug R&D enterprises with the aim of developing a range of CBD-based drugs that can help mitigate the suffering of patients with Alzheimer’s, among other diseases.

For more information, visit the company’s website at

About NetworkNewsWire

NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s